A Study of Docetaxel for Injection (Albumin-bound) in Patients With Gastric Cancer
Clinical trial NCT05705635 · UNKNOWN
Trial details
- NCT number
- NCT05705635
- Sponsor
- CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-13
- Primary completion
- 2023-05-01
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.